A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides
Public ClinicalTrials.gov record NCT00134498. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3, Multi-Site, Double-Blind, Randomized, Forced Titration, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Fixed Combination Torcetrapib (CP 529,414)/Atorvastatin Administered Orally, Once Daily (Qd) For Eighteen Weeks, Compared With Atorvastatin Alone, In Subjects With Fredrickson Type IV Hypertriglyceridemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Torcetrapib project was terminated on December 2, 2006 due to safety findings. To assess the safety and efficacy of the fixed combination torcetrapib/atorvastatin in subjects with Fredrickson Type IV Hypertriglyceridemia.
Study identification
- NCT ID
- NCT00134498
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Nov 2006 (Type not available)
- Last update posted
- Nov 16, 2007
2005 – 2006
United States locations
- U.S. sites
- 39
- U.S. states
- 23
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Anaheim | California | — | — |
| Pfizer Investigational Site | Huntington Beach | California | — | — |
| Pfizer Investigational Site | Los Angeles | California | — | — |
| Pfizer Investigational Site | Orange | California | — | — |
| Pfizer Investigational Site | Orangevale | California | — | — |
| Pfizer Investigational Site | Pacific Palisades | California | — | — |
| Pfizer Investigational Site | Studio City | California | — | — |
| Pfizer Investigational Site | Tustin | California | — | — |
| Pfizer Investigational Site | Walnut Creek | California | — | — |
| Pfizer Investigational Site | Farmington | Connecticut | — | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | — | — |
| Pfizer Investigational Site | Hollywood | Florida | — | — |
| Pfizer Investigational Site | Longwood | Florida | — | — |
| Pfizer Investigational Site | West Palm Beach | Florida | — | — |
| Pfizer Investigational Site | Tripler AMC | Hawaii | — | — |
| Pfizer Investigational Site | Chicago | Illinois | — | — |
| Pfizer Investigational Site | Indianapolis | Indiana | — | — |
| Pfizer Investigational Site | Overland Park | Kansas | — | — |
| Pfizer Investigational Site | Baton Rouge | Louisiana | — | — |
| Pfizer Investigational Site | Scarborough | Maine | — | — |
| Pfizer Investigational Site | Bethesda | Maryland | — | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | — | — |
| Pfizer Investigational Site | Canton | Michigan | — | — |
| Pfizer Investigational Site | Portage | Michigan | — | — |
| Pfizer Investigational Site | Richland | Michigan | — | — |
| Pfizer Investigational Site | Saint Cloud | Minnesota | — | — |
| Pfizer Investigational Site | Olive Branch | Mississippi | — | — |
| Pfizer Investigational Site | Jefferson City | Missouri | — | — |
| Pfizer Investigational Site | St Louis | Missouri | — | — |
| Pfizer Investigational Site | Las Vegas | Nevada | — | — |
| Pfizer Investigational Site | Rochester | New York | — | — |
| Pfizer Investigational Site | Syracuse | New York | — | — |
| Pfizer Investigational Site | West Seneca | New York | — | — |
| Pfizer Investigational Site | Statesville | North Carolina | — | — |
| Pfizer Investigational Site | Sellersville | Pennsylvania | — | — |
| Pfizer Investigational Site | Warwick | Rhode Island | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Richmond | Virginia | — | — |
| Pfizer Investigational Site | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00134498, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2007 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00134498 live on ClinicalTrials.gov.